ABC Arbitrage’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
Other funds holding DAWN
ABC Arbitrage's DAWN Position: Q2 2026 in Review
ABC Arbitrage sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 228,817 shares — an estimated $4.91M sold.
ABC Arbitrage first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $4.91M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.
- ABC Arbitrage reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
- ABC Arbitrage sold 228,817 Day One Biopharmaceuticals shares in Q2 2026, an estimated $4.91M.
- ABC Arbitrage first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
- ABC Arbitrage's Day One Biopharmaceuticals position peaked at $4.91M in Q1 2026.
- 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.
Based on ABC Arbitrage's 13F filing for Q2 2026, filed 20 Jul 2026.